Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Judit Axmann"'
Autor:
Toby M. Maher, Courtney Schiffman, Michael Kreuter, Catharina C. Moor, Steven D. Nathan, Judit Axmann, Paula Belloni, Monica Bengus, Frank Gilberg, Klaus-Uwe Kirchgaessler, Marlies S. Wijsenbeek
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Patients with interstitial lung disease (ILD) require regular physician visits and referral to specialist ILD clinics. Difficulties or delays in accessing care can limit opportunities to monitor disease trajectory and response to
Externí odkaz:
https://doaj.org/article/e408398a513e4a71a24021b423960045
Autor:
Maria Molina-Molina, Michael Kreuter, Vincent Cottin, Tamera J. Corte, Frank Gilberg, Klaus-Uwe Kirchgaessler, Judit Axmann, Toby M. Maher
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Approximately 12–13% of patients with interstitial lung disease (ILD) are diagnosed with unclassifiable ILD (uILD), often despite thorough evaluation. A recent Phase 2 study (NCT03099187) described a significant effect of pirfenidone vs. placebo on
Externí odkaz:
https://doaj.org/article/ee6f556226ca452ba20b217abf867f7c
Autor:
Toby M. Maher, Maria Molina-Molina, Anne-Marie Russell, Francesco Bonella, Stéphane Jouneau, Elena Ripamonti, Judit Axmann, Carlo Vancheri
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-12 (2017)
Abstract Background Two antifibrotic drugs, pirfenidone and nintedanib, are approved by the European Medicines Agency and the US Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis (IPF). In this analysis, treatment patter
Externí odkaz:
https://doaj.org/article/a06e7716edc34e21b03dbbea29530619
Autor:
Michael Kreuter, Toby M. Maher, Tamera J. Corte, Maria Molina-Molina, Judit Axmann, Frank Gilberg, Klaus-Uwe Kirchgaessler, Vincent Cottin
Publikováno v:
Advances in Therapy
Advances in Therapy, Springer Verlag (Germany), 2021, ⟨10.1007/s12325-021-02009-w⟩
Advances in Therapy, Springer Verlag (Germany), 2021, ⟨10.1007/s12325-021-02009-w⟩
International audience; Introduction : Il n'existe actuellement aucun traitement approuvé uniquement pour la maladie pulmonaire interstitielle inclassable (uILD) ; cependant, un essai récent a montré que cette population peut bénéficier de la pi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8123f020756f7de2f4f199cb8c5c39
http://hdl.handle.net/10044/1/93332
http://hdl.handle.net/10044/1/93332
Autor:
Judit Axmann, Maria Molina-Molina, Frank Gilberg, Toby M. Maher, Tamera J. Corte, Vincent Cottin, Michael Kreuter, Klaus-Uwe Kirchgaessler
Publikováno v:
Idiopathic interstitial pneumonias.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38e78e3515e6db248e4345dcf65dcf8c
https://doi.org/10.1183/13993003.congress-2020.1802
https://doi.org/10.1183/13993003.congress-2020.1802
Autor:
Elizabeth Morgenthien, Cindy Burg, Francis X. McCormack, Ming Yang, John L. Stauffer, Judit Axmann
Publikováno v:
Idiopathic interstitial pneumonias.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a04fb4b22e3ff813fd5dcaa439311572
https://doi.org/10.1183/13993003.congress-2020.783
https://doi.org/10.1183/13993003.congress-2020.783
Autor:
Judit Axmann, Toby M. Maher, Klaus-Uwe Kirchgaessler, Tamera J. Corte, Michael Kreuter, Vincent Cottin, Frank Gilberg, Maria Molina-Molina
Publikováno v:
A102. ILD DIAGNOSIS AND MONITORING.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c11a87fc497f7894f1a50d3ba4dc55d1
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2575
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2575
Autor:
Toby M. Maher, Frank Gilberg, Vincent Cottin, Judit Axmann, Tamera J. Corte, Michael Kreuter, Klaus-Uwe Kirchgaessler, Maria Molina-Molina
Publikováno v:
C22. ILD THERAPY III.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c8e6c9b3755917a6016722be0d88e75
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4557
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4557
Autor:
Marlies S. Wijsenbeek, Jeffrey J. Swigris, Toby M. Maher, Steven D. Nathan, Judit Axmann, Lucy Ireland, Nicola Cassidy, Michael Kreuter
Publikováno v:
Respiration, 96(6), 514-524. Karger
Background: Antifibrotics are recommended for the treatment of individuals with idiopathic pulmonary fibrosis (IPF), but treatment use remains at ∼60%. Objective: To investigate the views of individuals with IPF and pulmonologists on the diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db89cab5a70a16ba0f16082e2318b52d
https://doi.org/10.1159/000490667
https://doi.org/10.1159/000490667
Autor:
David J. Lederer, Vincent Cottin, Judit Axmann, Frank Gilberg, Katerina Samara, Tamera J. Corte, Toby M. Maher, Klaus-Uwe Kirchgaessler, Aryeh Fischer, Maria Molina-Molina, Michael Kreuter
Publikováno v:
Idiopathic interstitial pneumonias.
Introduction: There are no approved therapies for patients with uILD, who may have irreversible ILD. We evaluated efficacy and safety of pirfenidone in patients with progressive fibrosing uILD. Methods: This was a double-blind, randomised, placebo-co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1fd7f2f73b2fb5e7b7afbfbc6c24ad4
https://doi.org/10.1183/13993003.congress-2019.rct1880
https://doi.org/10.1183/13993003.congress-2019.rct1880